Interventional Cardiology: Implantable Cardioverter Defibrillators

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable cardioverter defibrillator (ICD) products market. Types of cardiac defibrillators covered by the scope of this report include ICDs, subcutaneous ICDs (S-ICDs), and cardiac resynchronization therapy-defibrillators (CRT-Ds). 

The combined global market for ICD devices totals nearly $8bn, and is expected to climb at a CAGR of 4.4% through 2023. The most influential driver of the global ICDs market is the increasing prevalence of cardiovascular disease (CVD) as a result of the expanding geriatric population and an increasing prevalence of CVD risk factors such as obesity and diabetes.